{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -3.2258062, "regularMarketPrice": 0.21, "exchange": "FRA", "shortName": "RHYTHM BIOSCIENCES LTD", "longName": "Rhythm Biosciences Limited", "messageBoardId": "finmb_540780120", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.21, "regularMarketDayRange": "0.21 - 0.21", "regularMarketDayLow": 0.21, "regularMarketPreviousClose": 0.217, "bid": 0.209, "ask": 0.231, "fullExchangeName": "Frankfurt", "financialCurrency": "AUD", "regularMarketOpen": 0.21, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0109999925, "fiftyTwoWeekLowChangePercent": 0.055276345, "fiftyTwoWeekRange": "0.199 - 0.594", "fiftyTwoWeekHighChange": -0.384, "fiftyTwoWeekHighChangePercent": -0.64646465, "fiftyTwoWeekLow": 0.199, "fiftyTwoWeekHigh": 0.594, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 217168000, "bookValue": 0.04, "fiftyDayAverage": 0.4917, "fiftyDayAverageChange": -0.28170002, "fiftyDayAverageChangePercent": -0.57291037, "twoHundredDayAverage": 0.4974074, "twoHundredDayAverageChange": -0.2874074, "twoHundredDayAverageChangePercent": -0.5778108, "marketCap": 64339168, "priceToBook": 5.25, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1676962800000, "priceHint": 4, "regularMarketChange": -0.0069999993, "symbol": "0RY.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Bio21 Institute", "address2": "30 Flemington Road", "city": "Parkville", "state": "VIC", "zip": "3010", "country": "Australia", "phone": "61 3 8256 2880", "website": "https://www.rhythmbio.com", "industry": "Diagnostics & Research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD", "age": 58, "title": "Exec. Chairman", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 88991, "fmt": "88.99k", "longFmt": "88,991"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Trevor John Lockett Ph.D.", "title": "Technical Director, Chair of the Clinical Advisory Board & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 88149, "fmt": "88.15k", "longFmt": "88,149"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul  Smith", "title": "Chief Financial Officer & Joint Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Andrea  Steele LLB B Com LLM", "title": "Gen. Counsel & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elena  Deak", "title": "Chief Commercial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}